Cost, Value and Access of Personalized Medicine

Linda D. Bosserman, MD, FACP

Video Categories: Value

Linda Bosserman provides an overview of the nuances of personalized medicine as it relates to cost, value and access
July 17, 2018

How the Treatment of Lung Cancer Has Been Transformed in the Era of Molecular Biomarker Testing

Drs Roy Herbst and David Rimm review how biomarker testing has transformed the way patients with lung cancer are treated, and how both medical oncologists and pathologists contribute to these changes.

September 20, 2013

The Greatest Value of Personalized Medicine

Grant Lawless discusses the definition of value in personalized medicine from different perspectives